Jack Rosenfeld
Family Medicine · Lansdale, PANPI 1558368811
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 427 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 427 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$757
- Novo Nordisk$502
- AstraZeneca$469
- Lilly USA, LLC$431
- Kowa Pharmaceuticals America, Inc.$387
- plus $3K from 43 others
Across 31 payments — averaging $2893.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$46K
- Bayer$19K
- Merck$11K
- Kowa Research Institute, Inc.$9K
- AstraZeneca$4K
- Akcea Therapeutics, Inc.$1K
What the payments were for
- Consulting fees$2504%
- Food & beverage$6,51696%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANORO ELLIPTA$250
How this compares
$6,778 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 37 | $601 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $453 |
| Levothyroxine Sodium | 39 | $447 |
| Losartan Potassium | 30 | $416 |
| Metformin Hcl | 22 | $317 |
| Pantoprazole Sodium | 13 | $315 |
| Rosuvastatin Calcium | 20 | $293 |
| Lisinopril | 29 | $223 |
| Metoprolol Succinate | 15 | $156 |
| Omeprazole | 18 | $149 |
| Simvastatin | 21 | $139 |
| Amlodipine Besylate | 14 | $67 |
| Hydrochlorothiazide | 18 | $46 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lansdale
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.